354. Deputy Ken O'Flynn asked the Minister for Justice, Home Affairs and Migration the average financial support paid per person and per family unit under the voluntary return programme in each of the past five years. [52769/25]
355. Deputy Ken O'Flynn asked the Minister for Justice, Home Affairs and Migration the total administrative cost of operating the voluntary return programme in each of the past five years, including staffing, promotion and case management. [52770/25]
356. Deputy Ken O'Flynn asked the Minister for Justice, Home Affairs and Migration the number of applications made to the voluntary return programme in each of the past five years, the number approved, the number refused; and the number of approved applicants who subsequently did not depart the State. [52771/25]
357. Deputy Ken O'Flynn asked the Minister for Justice, Home Affairs and Migration the criteria and process used by his Department in assessing applications to the voluntary return programme; and the grounds on which applications are refused. [52772/25]
358. Deputy Ken O'Flynn asked the Minister for Justice, Home Affairs and Migration whether his Department has commissioned or received any independent evaluations or audits of the effectiveness of the voluntary return programme since its introduction in 2009; and if so, to make such reports publicly available. [52773/25]
359. Deputy Ken O'Flynn asked the Minister for Justice, Home Affairs and Migration the estimated cost per successful voluntary return in each of the past five years, including both grant support and administrative overheads, and to provide a comparison with the estimated cost of enforced deportations in the same period. [52774/25]
360. Deputy Ken O'Flynn asked the Minister for Justice, Home Affairs and Migration the top ten countries of nationality of those availing of the voluntary return programme in each of the past five years; and the number of returns for each nationality. [52775/25]
361. Deputy Ken O'Flynn asked the Minister for Justice, Home Affairs and Migration if he will commit to publishing an annual statistical report on the voluntary return programme, setting out in anonymised form the number of applicants, approvals, refusals, grant levels, nationalities involved, and overall expenditure. [52776/25]
363. Deputy Ken O'Flynn asked the Minister for Justice, Home Affairs and Migration the safeguards currently in place within the International Protection Office to detect coached or rehearsed asylum claims; and if he will make a statement on the matter. [52782/25]
364. Deputy Ken O'Flynn asked the Minister for Justice, Home Affairs and Migration the number of international protection applications since 2020 that have been refused, withdrawn, or deemed in admissible following concerns about fabricated, coached, or inconsistent testimony; if he will provide this data on an annual basis; and if he will make a statement on the matter. [52783/25]
365. Deputy Ken O'Flynn asked the Minister for Justice, Home Affairs and Migration the nature of the training provided to International Protection Office caseworkers in order to identify coached or scripted interview responses; and if he is satisfied that these procedures are adequate. [52784/25]
366. Deputy Ken O'Flynn asked the Minister for Justice, Home Affairs and Migration if his Department has identified the circulation of coaching documents, interview scripts, or similar materials for asylum applicants; the steps taken when such documents are discovered; and if he will make a statement on the matter. [52785/25]
367. Deputy Ken O'Flynn asked the Minister for Justice, Home Affairs and Migration the penalties or consequences for applicants who knowingly submit false or coached claims; and whether he intends to strengthen such measures to safeguard the integrity of the asylum system. [52786/25]
452. Deputy Ken O'Flynn asked the Minister for Health the number of oncology drugs approved for use by the European Medicines Agency in each of the years 2020 to 2025; and to specify which of these are currently reimbursed under the public health system, which are only available privately, and the average waiting time from EMA approval to HSE reimbursement. [52823/25]
453. Deputy Ken O'Flynn asked the Minister for Health whether there are cancer drugs currently accessible to private patients in Ireland which are not reimbursed for public patients; and the steps being taken to eliminate this disparity in access. [52824/25]
454. Deputy Ken O'Flynn asked the Minister for Health the average time taken by the National Centre for Pharmacoeconomics and her Department to complete health technology assessments and reimbursement decisions on oncology drugs in the past three years; and whether target timelines exist to expedite access for public patients. [52825/25]
455. Deputy Ken O'Flynn asked the Minister for Health if her Department has entered into outcomes-based or risk-sharing agreements with pharmaceutical companies in respect of new cancer drugs; and if so, to provide details of the drugs concerned, the duration of the agreements, and the outcomes being measured. [52826/25]
456. Deputy Ken O'Flynn asked the Minister for Health the projected level of additional annual funding required over the next five years to ensure that all newly approved cancer drugs are made available to public patients in a timely manner; and whether ring-fenced oncology funding is being considered within her Department. [52827/25]
457. Deputy Ken O'Flynn asked the Minister for Health whether her Department has carried out any equality or impact assessment on disparities in access to oncology drugs between public and private patients; and if so, to publish those findings. [52828/25]
458. Deputy Ken O'Flynn asked the Minister for Health to provide comparative data on the time from European Medicines Agency approval to reimbursement for new oncology medicines in Ireland versus other EU member states; and to indicate whether Ireland is above or below the EU average. [52829/25]
459. Deputy Ken O'Flynn asked the Minister for Health if she will publish in full the rationale, minutes, and assessments underpinning reimbursement decisions on oncology drugs since 2020; and if not, the reason for the continued confidentiality. [52830/25]
460. Deputy Ken O'Flynn asked the Minister for Health whether a national registry of oncology patients treated with newer cancer therapies is maintained; and if so, to outline how this real-world data informs reimbursement and future access decisions. [52831/25]
461. Deputy Ken O'Flynn asked the Minister for Health the steps being taken to accelerate the availability of oncology generics and biosimilars to reduce cost barriers for the public health system; and whether legislative or regulatory reform is being considered in this regard. [52832/25]
116. Deputy Ken O'Flynn asked the Minister for Justice, Home Affairs and Migration for a list of all properties currently owned, leased, or otherwise used by an organisation (details supplied) or by any of its subsidiaries or affiliates, for the purpose of providing accommodation under contracts or funding arrangements with his Department, including through the International Protection Accommodation Services; and to …
117. Deputy Ken O'Flynn asked the Minister for Justice, Home Affairs and Migration to provide the total value of contracts awarded to an organisation (details supplied), or to any of its subsidiaries or affiliates, for the provision of accommodation under the International Protection Accommodation Services, by year from 2020 to date in 2025; and to outline whether these contracts were awarded by open tender, direct a…